Effects of [norleucine27] growth hormone-releasing hormone (GHRH) (1- 29)-NH2 administration on the immune system of aging men and women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3590-3596

  Khorram, O ^a,c   Yeung, M ^a,b   Vu, L ^a   Yen, S S C ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Clayton Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR[1-29]; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PLACEBO; UNCLASSIFIED DRUG; [27 NORLEUCINE]GROWTH HORMONE RELEASING FACTOR[1-29] AMINE; DRUG DERIVATIVE; HUMAN GROWTH HORMONE; SERMORELIN; SOMATOMEDIN C; SOMATOTROPIN (1 29)AMIDE, NLE(27); SOMATOTROPIN (1-29)AMIDE, NLE(27)-;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SELF ADMINISTRATION; FEMALE; FLOW CYTOMETRY; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; AGED; AGING; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETICS; IMMUNITY; METABOLISM; MIDDLE AGED; PERIODICITY; RANDOMIZED CONTROLLED TRIAL; SECRETION; T LYMPHOCYTE;

PHYTOLACCACEAE; STAPHYLOCOCCUS AUREUS;

AGED; AGING; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMAN GROWTH HORMONE; HUMANS; IMMUNITY; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-2; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PERIODICITY; RNA, MESSENGER; SERMORELIN; T-LYMPHOCYTES;

EID: 0030612858     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.11.3590     Document Type: Article

References (46)

1. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
2. Miller RA. 1991 Aging and immune function. Int Rev Cytol. 124:187-215.3.
3. Clark R. 1997 The somatogenic hormones and insulin-like growth factor-I: stimulators of lymphopoiesis and immune function. Endocr Rev. 18:157-179.
4. Kelly KW. 1991 The role of growth hormone in modulation of the immune response. Ann NY Acad Sci. 95-103.
5. Gala RR. 1991 Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med. 198:513-527.
6. Auernhammer CJ, Strasburger CJ. 1995 Effect of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol. 133:635-645.
7. Kelly KW, Brief S, Westly HJ, et al. 1986 GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA. 83:5663-5667.
8. Monroe WE, Roth JA, Grier RL, Arp LH, Naylor PH. 1987 Effects of growth hormone on the adult canine thymus. Thymus. 9:173-187.
9. Davila DR, Brief S, Sun J, Hammer RE, Brinster RL, Kelley KW. 1987 Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents. J Neurosci Res. 18:108-116.
10. Guler H, Zapf J, Scheiwiller E, Froesch E. 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA. 85:4889-4893.
11. Wu H, Devi R, Malarkey WB. 1996 Localization of growth hormone messenger ribonucleic acid in the human immune system - a clinical research center study. J Clin Endocrinol Metab. 81:1278-1282.
12. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi N. 1994 Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin. J Clin Endocrinol Metab. 79:1678-1680.
13. Hattori N, Shimomura K, Ishihara T. 1993 Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by insulin-like growth factor-I. J Clin Endocrinol Metab. 76:937-939.
14. Sabharwal P, Varma S. 1996 Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab. 81:2663-2669.
15. Baxter JB, Blalock JE, Weigent DA. 1991 Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology. 129:1727-1734.
16. Campbell RM, Scanes CG. 1995 Endocrine peptides "moonlighting" as immune modulators; roles for somatostatin and GH-releasing factor. J Endocrinol. 147:383-396.
17. Weigent DA, Blalock JE. 1990 Immunoreactive growth-hormone releasing hormone in rat lymphocytes. J Neuroimmunol. 29:1-13.
18. Guarcello V, Weigent DA, Blalock JE. 1991 Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats. Cell Immunol. 135:29-32.
19. Weigent DA, Riley JA, Galin FS, LeBoeuf RD, Blalock JE. 1991 Detection of growth hormone and growth-hormone releasing hormone-related messenger RNA in rat leukocytes by the polymerase chain reaction. Proc Soc Exp Biol Med. 198:643-648.
20. Stephanou A, Knight RA,Lightman SL. 1991 Production of growth-hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. Neuroendocrinology. 53:628-633.
21. Zelazowski P, Dohler KD, Stepien H, Pavlikowski M. 1989 Effect of growth-hormone releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects. Neuroendocrinology. 50:236-239.
22. Siriani MC, Annibale B, Tagliaferi F, et al. 1992 Modulation of human natural killer activity by vasoactive intestinal polypeptide (VIP) family. VIP, glucagon, and GHRF specifically inhibit NK activity. Regul Pept. 38:79-87.
23. Valtorta A, Maretta A, Maccario A, Bozzola M, Severi F. 1991 Influence of growth hormone-releasing hormone (GHRH) on phytohemagglutinin-induced lymphocyte activation; comparison of two synthetic forms. Thymus. 18:51-59.
24. Abbassi B, Bellonti JA. 1985 Hormonal and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone. Pediatr Res. 19:299-301.
25. Rapaport R, Oleske J, Ahdieh H, et al. 1987 Effects of human growth hormone on immune function:in vitro studies on cells of normal and growth-deficient children. Life Sci. 41:2319-2324.
26. Spadoni GL, Rossi P, Ragno W, et al. 1991 Immune function in growth hormone-deficient children treated with biosythetic growth hormone. Acta Paediatr. 80:75-79.
27. Bozzola M, Cisernino M, Valtorta A, et al. 1989 Effect of biosynthetic methionyl growth hormone (GH) therapy on the immune function in GH-deficient children. Horm Res. 31:153-156.
28. Crist DM, Peake GT, Mackinnoa LT, Sibbitt WL, Kramer JC. 1989 Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism. 36:1115-1119.
29. Kiess W, Doerr H, Butenandt O, Belohradsky O. 1986 Lymphocyte subsets and natural-killer activity in growth hormone deficiency. New Engl J Med. 314:321.
30. Kiess W, Malozowski S, Gelato M, et al. 1988 Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. Clin Immunol Immunopathol. 48:85-94.
31. LeRoith D, Yanowski J, Kaldjian EP, et al. 1996 The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology. 137:1071-1079.
32. Vance ML, Evans WS, Kaiser DL, et al. 1986 The effect of intravenous, subcutaneous, and intramural GHRH analog, [Nle27]GHRH(1-29)NH2 on growth hormone secretion in normal men: dose-response relationships. Clin Pharmacol Ther. 10:627-633.
33. Coligan JE, Kruisbect AM, Margulies DM, Shevach EM, Strober W, eds. 1992 Current protocols in immunity. New York: Greene Publishing Associates and Wiley Intersciences.
34. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thymocyte-pheno-chloroform extraction. Anal Biochem. 162:156-159.
35. Yeung MC, Pulliam L, Lau AS. 1995 The HIV membrane gp120 is toxic to human brain cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 9:137-143.
36. Southern EM. 1975 Detection of specific sequences among DNA fragment separated by gel electrophoresis. J Mol Biol. 98:503-517.
37. Church GM, Gilbert W. 1984 Genomic sequencing. Proc Natl Acad Sci USA. 81:1991-1995.
38. Sambrook I, Fritsch EF, Maniatis T. 1989 Molecular cloning. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1014.
39. Khorram O, Laughlin G, Yen SSC. 1997 Endocrine and metabolic effects of long-term administration of [Nle27] growth hormone-releasing hormone (GHRH)(1-29)NH2 in age-advanced men and women. J Clin Endocrinol Metab. 82:1472-1479.
40. Mowles TF, Stricker P, Felix AM, Soike KF, Campbell RM. 1991 Effect of human growth hormone-releasing factor and a potent analog on antibody formation in African Green Monkey. Horm Metab Res. 23:530-534.
41. Abbas AK, Lichtman AH, Pober JS, eds. 1994 Cellular and molecular immunology. New York: W. B. Saunders; 136.
42. Espinoza-Delgado T, Bosco MC, Musso T, Guselli GL, Longo DL, Veresco L. 1995 Interleukin-2 and human monocyte activation. J Leukoc Biol. 57:13-19.
43. Kimata H, Yoshida A. 1994 Effect of growth hormone and insulin-like growth factor I on immunoglobulin production and growth of human B cells. J Clin Endocrinol Metab. 78:635-641.
44. Botteri FM, Van der Putten H, Wong DF, Sauvage CA, Evans RM. 1987 Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen. Mol Cell Biol. 7:3178-3184.
45. Blazar BR, Brennan CA, Broxmeyer HE, Schultz LD, Vallera DA. 1995 Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo. Exp Hematol. 22:1397-1406.
46. Westermann J, Pabst R. 1990 Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today. 11:406-410.